Blood‒Brain Barrier Pathology and CNS Outcomes in Streptococcus pneumoniae Meningitis

B Yau, NH Hunt, AJ Mitchell, LK Too - International journal of molecular …, 2018 - mdpi.com
Streptococcus pneumoniae is a major meningitis-causing pathogen globally, bringing about
significant morbidity and mortality, as well as long-term neurological sequelae in almost half …

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a …

PC Valery, PS Morris, CA Byrnes… - The lancet Respiratory …, 2013 - thelancet.com
Background Indigenous children in high-income countries have a heavy burden of
bronchiectasis unrelated to cystic fibrosis. We aimed to establish whether long-term …

Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of …

GA Mackenzie, AJ Leach, JR Carapetis, J Fisher… - BMC infectious …, 2010 - Springer
Background To determine the prevalence of carriage of respiratory bacterial pathogens, and
the risk factors for and serotype distribution of pneumococcal carriage in an Australian …

[HTML][HTML] General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive …

AJ Leach, C Wigger, J Beissbarth, D Woltring… - International journal of …, 2016 - Elsevier
Objectives This study aims to monitor the prevalence of suppurative otitis media in remote
Indigenous communities after introduction of 13-valent pneumococcal conjugate vaccine …

[HTML][HTML] Immune responses to pneumococcal vaccines in children and adults: rationale for age-specific vaccination

MAJ Westerink, HW Schroeder Jr, MH Nahm - Aging and disease, 2012 - ncbi.nlm.nih.gov
Streptococcus pneumoniae is a significant human pathogen and currently available
pneumococcal vaccines are designed to elicit anti-capsule antibodies. The 23-valent …

The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of …

D Lehmann, J Willis, HC Moore, C Giele… - Clinical Infectious …, 2010 - academic.oup.com
Abstract Background. In 2001, Australia introduced a unique 7-valent pneumococcal
conjugate vaccine (7vPCV) 2-, 4-, and 6-month schedule with a 23-valent pneumococcal …

Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable …

AJ Leach, C Wigger, K Hare, V Hampton, J Beissbarth… - BMC pediatrics, 2015 - Springer
Abstract Background In October 2009, 7-valent pneumococcal conjugate vaccine (PCV7:
Prevenar TM Pfizer) was replaced in the Northern Territory childhood vaccination schedule …

Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules

AJ Leach, C Wigger, R Andrews, M Chatfield… - BMC pediatrics, 2014 - Springer
Background In 2001 when 7-valent pneumococcal conjugate vaccine (PCV7) was
introduced, almost all (90%) young Australian Indigenous children living in remote …

Risk factors for carriage of antibiotic-resistant bacteria in healthy children in the community: a systematic review

NL Messina, DA Williamson… - The Pediatric …, 2020 - journals.lww.com
Background: In addition to health care settings, antibiotic resistance has also been
increasing in the community. Healthy children represent an important potential reservoir of …

[HTML][HTML] Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD …

J Beissbarth, N Wilson, B Arrowsmith, MJ Binks… - Vaccine, 2021 - Elsevier
Abstract Background Aboriginal children in Northern Australia have a high burden of otitis
media, driven by early and persistent nasopharyngeal carriage of otopathogens, including …